Mass flows of 13 pharmaceutical active ingredients (APIs) found in drinking water were studied in the water cycle of Stockholm. Data were collected by analyzing samples of surface water, raw water and drinking water as well as influents, effluents and sludges from waste water treatment plants (WWTPs) in Stockholm area. A mass balance was performed, based on sold amounts of pharmaceuticals and the measured concentrations in water and sludge. The selected APIs were all present in WWTP effluents and the removal rates for many of them were poor. Mass balance calculations showed that the three studied WWTPs in Stockholm release considerable amounts of the selected APIs into the Baltic Sea while the portions ending up in WWTP sludge were significantly lower. The levels of APIs found in drinking water are low at present, but may increase in the future unless the releases from WWTPs in the catchment of Lake Mälaren are mitigated.
INTRODUCTION
In Sweden, a concern has been expressed for effects on humans in a longer perspective due to lifetime exposure of the whole population to APIs from drinking water. As the consumption of pharmaceuticals is steadily increasing (Bengtsson et al. ) this may pose a threat to coming generations. There is a growing pressure on local authorities (city councils, regional authorities) to address the concern, e.g., undertake measures to protect population and the environment. Basic knowledge of the mass flow of APIs through/within a community (city, region) can in this respect provide a tool helping to identify targets for possible measures.
The aim of the present study is to investigate flows of 13 selected APIs in the water cycle of Stockholm. The selection is limited to the APIs found most abundant in raw water and/or drinking water in Stockholm. With a few exceptions indicated in the text, the data presented here have been generated within the study using chemical analysis of waste waters, drinking water, receiving waters as well as sewage sludge. The study is a part of a larger project where 84-96 different pharmaceuticals were analysed (Wahlberg et al.
).

METHODS
Selected APIs
The 13 Approximately 4% of this water is used for the production of drinking water for the Stockholm region by three drinking water works -Norsborg, Lovö and Görväln (Figure 1 ), serving 1,500,000 persons in total. The treatment process in Norsborg and Lovö consists of flocculation, sedimentation, and a rapid filtration through sand filters followed by slow sand filtration with two to three hours retention time, which allows some biological activity in the filters.
The plant at Görväln uses the same processes but instead of the slow sand filtration, an active carbon filter is used as a bio filter. All three water works employ ultra violet light and monochloramine for disinfection and lime for pH-adjustment. The average daily production is 480,000 m 3 .
Sampling procedures
Samples of surface waters from Lake Mälaren and from the receiving waters in the Stockholm archipelago of the Baltic Sea were collected as grab samples. Two sampling points at Lake Mälaren were chosen close to the water intakes and one point, Centralbron, in the city centre, upstream the WWTP outlets. In the archipelago, six sampling points were selected in a gradient from the WWTP outlets, following the route which the waste water current takes towards northeast and then southwards after Oxdjupet to the most remote point approximately 60 km from the outlet (Figure 1 ).
Influents and effluents from the drinking water treatment plants were taken as grab samples while influents and effluents from the WWTPs were collected as 24-hour flow proportional samples during the same day. Digested sludges were grab sampled.
Calculating mass flows
The inflow system border for the mass flow model is drawn a few kilometres upstream the waterworks in Lake Mälaren In the present study, no samples of hospital waste water were taken. Instead, data for the Swedish hospitals were extracted from a database on analytical data provided by the Stockholm County Council (Wennmalm ) . The inflow to the hospitals is included in the main inbox, 'in medicine'.
RESULTS AND DISCUSSION
The results from the chemical analysis are presented in Table 1 , where the figures in brackets correspond to the number of analyzed samples and the number of samples where the API was found. The numbers marked with "<"
correspond to the analytical limits of detection. Any definitive conclusion whether a general removal of APIs occurs in the water works can not be drawn. However, as can be seen from Table 1 , several APIs, such as diclofenac, atenolol, naproxen, and trimethoprim, appear to exhibit a shift to lower concentration ranges and/or lower detection frequency from raw water to drinking water.
The levels of APIs in drinking water (Table 1) 
Presence and removal of APIs in waste water treatment
In waste water influents, ibuprofen and naproxen were found at the highest concentrations of 3,800-11,000 ng/L and 2,000-4,100 ng/L, respectively. Furosemide, atenolol and metoprolol, present in influent in average concentrations of 900-1,600 ng/L were found at the highest concentrations in the effluent.
The removal rates for the selected APIs, defined as the difference between the concentration in the influent and effluent divided by the concentration in the influent and multiplied by 100%, were calculated using 13 pairs of the corresponding influent and effluent samples (Table 1 ). This resulted in more than 20% mean reduction in the concentrations for 7 of the 13 compounds. The removal rates of ibuprofen and naproxen were consistently high, 98 and 81%, respectively. Practically no removal in the wastewater treatment process was observed for oxazepam and cetirizine, while 'negative' reduction rates were observed for citalopram, metoprolol, dextropropoxiphene, and tramadol, i.e., the effluents had higher concentrations than the influents. 
Levels of APIs in the receiving waters
The same APIs that were found in samples from Lake Mäla-ren and the drinking water were also found in the receiving waters of the Stockholm WWTPs as illustrated in Figure 2 .
Four samples (three for tramadol) were analysed at each point. At Blockhusudden, the first sampling point of 2.5 and 3.5 kilometres downstream the outlets from Henriksdal and Bromma WWTP respectively, all 13 substances were 
Mass flow analysis -summary
The results for all substances are summarized in Table 2 .
The assumed 100% excretion of parent substance after the intake is, probably, the major reason for the discrepancy between the input mass of the API calculated from medicines and the mass of the API found in the WWTP influents.
Considering different sources, the largest input is from 
CONCLUSIONS
The 13 studied APIs were found in discharges from WWTP effluents as well as in drinking water and surface water samples. The existing wastewater treatment seems to be ineffective in removing the studied pharmaceuticals from the water phase with the result that the three studied WWTPs in Stockholm release a considerable amount of APIs into the 
